Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The risk that genetic engineering will be used to achieve non-medical results

Michael Kirsch, MD
Conditions
August 12, 2017
Share
Tweet
Share

We cannot let the anecdote rule over us.   We don’t make sound policy if we are swayed by isolated emotional vignettes.  Of course, a vignette describes a living, breathing human being, but we must consider the greater good, the overall context and the risk of letting our hearts triumph over our heads when making general policy.  Consider these examples.

If an expensive drug treatment program keeps five addicts clean for six months, do we champion this success in asking for funding to be renewed while omitting that 400 enrolled addicts failed?

If an experimental medical treatment seems to be effective in one patient with a stubborn disease, should physicians lurch toward it leaving aside standard treatments which have been subjected to Food and Drug Administration approval and years of clinical experience?

If a high school student attends a SAT prep course and achieves a near perfect score, do we conclude that every student should enroll in this course?

It is natural to be drawn to a shiny object, but on closer review, the shine often tarnishes quickly.

Recently, we learned of an astonishing scientific breakthrough that seems utterly fantastic and futuristic, even though it has actually occurred. Scientists amended the DNA of human embryos to correct a mutation – a genetic defect – that causes a very serious medical disease.   This suggests that with additional research and testing that embryos who otherwise might be destined for misery could be rescued.

We will hear heartwarming and breathtaking anecdotes that, if considered in isolation, will generate excitement and support.

Would you argue against the following headlines?

Embryo with fatal cystic fibrosis mutation saved.

Tay-Sachs embryo rescued from fatal outcome.

Hemophiliac embryo expected to live normal life.

As is always the case, there will be ethical mission creep, despite the usual bromides that “scientists and research institutions will conform to the highest ethical standards.”   The fact that there is a fortune to be made in the genetics industry can be expected to alter the direction of our ethical compass.  And, while the initial rollout will be discussing how genetic intervention can reverse the course of devastating and fatal diseases, does anyone believe it will stop there?  Once the concept has been normalized, other medical conditions will be targeted.   The creep will be inexorable.  Boundaries will be shattered.

Should we?

ADVERTISEMENT

Who doesn’t want a perfect child?  Over time, how will all of us regard the disabled community or even folks of average intellect and ability?  Will a disabled person be defined as anyone who is imperfect?

Beyond medical mission creep, I believe there is a very serious risk that genetic engineering will be used to achieve non-medical results.

Imagine that you are new parents.  If medical science could perform a procedure that would add 20 IQ points to your child, would you pursue it?  Would you submit to a minor DNA tinker that would produce an excellent athlete or a musician?  See where I’m going with this?

Are you really ready for the curtain to rise on the genetic engineering show?  I’m not.  To me, all this sounds like coming attractions of a horror show.

Michael Kirsch is a gastroenterologist who blogs at MD Whistleblower.

Image credit: Shutterstock.com

Prev

It's time to consider blockchain technology for EHRs

August 12, 2017 Kevin 0
…
Next

A emergency physician's compelling journey

August 13, 2017 Kevin 0
…

Tagged as: Genetics, Pediatrics

Post navigation

< Previous Post
It's time to consider blockchain technology for EHRs
Next Post >
A emergency physician's compelling journey

ADVERTISEMENT

More by Michael Kirsch, MD

  • Are Ozempic patients on a slow-moving runaway train?

    Michael Kirsch, MD
  • AI-driven diagnostics and beyond

    Michael Kirsch, MD
  • The surprising truth behind virtual visits

    Michael Kirsch, MD

Related Posts

  • Digital advances in the medical aid in dying movement

    Jennifer Lynn
  • Uninsured medical students are at risk

    Zannah Herridge-Meyer, Melanie Langa, and Kelly Stewart
  • The risk physicians take when going on social media

    Anonymous
  • How the COVID-19 pandemic highlights the need for social media training in medical education 

    Oscar Chen, Sera Choi, and Clara Seong
  • Qualifying conditions for medical marijuana

    Patricia Frye
  • End medical school grades

    Adam Lieber

More in Conditions

  • Is direct primary care sustainable in a downturn?

    Dana Y. Lujan, MBA
  • How movement improves pelvic floor function

    Martina Ambardjieva, MD, PhD
  • How immigrant physicians solved a U.S. crisis

    Eram Alam, PhD
  • Pediatric leadership silence on FDA ADHD recall

    Ronald L. Lindsay, MD
  • The ethical conflict of the Charlie Gard case

    Timothy Lesaca, MD
  • The ethics of mandatory Tay-Sachs testing

    Sheryl J. Nicholson
  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Rediscovering the sacred power of the patient story [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • Aging parents and Thanksgiving: a gentle check-in

      Barbara Sparacino, MD | Conditions
    • Physician legal rights: What to do when agents knock

      Muhamad Aly Rifai, MD | Physician
    • Trauma in high-functioning adults

      Ronke Lawal | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Systematic neglect of mental health

      Ronke Lawal | Tech
  • Recent Posts

    • Rediscovering the sacred power of the patient story [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • The human element in clinical trials

      Dr. Bodhibrata Banerjee | Physician
    • Is direct primary care sustainable in a downturn?

      Dana Y. Lujan, MBA | Conditions
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Transforming patient fear into understanding through clear communication [PODCAST]

      The Podcast by KevinMD | Podcast
    • How movement improves pelvic floor function

      Martina Ambardjieva, MD, PhD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 2 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Rediscovering the sacred power of the patient story [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • Aging parents and Thanksgiving: a gentle check-in

      Barbara Sparacino, MD | Conditions
    • Physician legal rights: What to do when agents knock

      Muhamad Aly Rifai, MD | Physician
    • Trauma in high-functioning adults

      Ronke Lawal | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Systematic neglect of mental health

      Ronke Lawal | Tech
  • Recent Posts

    • Rediscovering the sacred power of the patient story [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • The human element in clinical trials

      Dr. Bodhibrata Banerjee | Physician
    • Is direct primary care sustainable in a downturn?

      Dana Y. Lujan, MBA | Conditions
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • Transforming patient fear into understanding through clear communication [PODCAST]

      The Podcast by KevinMD | Podcast
    • How movement improves pelvic floor function

      Martina Ambardjieva, MD, PhD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The risk that genetic engineering will be used to achieve non-medical results
2 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...